Well Worth Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.20 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -34.54%
- Profit Growth -101.84%
- Ebitda -114.93%
- Net Worth -0.13%
- Total Assets 43.37%
About Well Worth Life Sciences
Well Worth Life Sciences Private Limited (WWLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 March 2014 and has a history of Ten years and 11 months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Mohamed Arafath and Anwar Safrin serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TN2014PTC095430
- Company No.
095430
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
What products or services does Well Worth Life Sciences Private Limited offer?
Well Worth Life Sciences Private Limited offers a wide range of products and services, including Animal Clothing & Accessories, Dog Accessories, Pet Furniture & Products, Pet Grooming Tools, Bird Food, Poultry & Animal Food, Dog Food, Pet Food, Dog Bones, Pet Accessories, Pet Cage.
Who are the key members and board of directors at Well Worth Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohamed Arafath  | Director | 13-Mar-2014 | Current |
| Anwar Safrin | Director | 04-May-2023 | Current |
Financial Performance of Well Worth Life Sciences.
Well Worth Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 34.54% decrease. The company also saw a substantial fall in profitability, with a 101.84% decrease in profit. The company's net worth dipped by a decrease of 0.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Well Worth Life Sciences?
In 2018, Well Worth Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Well Worth Life Sciences?
Unlock and access historical data on people associated with Well Worth Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Well Worth Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Well Worth Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
